WINSLOW GARRETT (General Counsel) sold 31.8% of their position (471.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2025ACC: 0000950170-25-002814
Officer· General Counsel
Since May 2021
+5.53K
Net shares
Net buyer
$2.6K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
7.32K acquired · 1.79K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.32K
Price / share
—
Trade value
—
% of position
825.0%
1/3/2025
160.00→1.48K
Common Stock
Direct
Shares
−471.00
Price / share
$5.60
Trade value
$2.64K
% of position
31.8%
1/3/2025
1.48K→1.01K
Total
Net shares
+849.00
Net value
-$2.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | M · Option Exercise | +1.32K | — | — | 825.0% | 160.00 | 1.48K |
| Common Stock Direct | 1/3/2025 | S · Sale | −471.00 | $5.60 | $2.64K | 31.8% | 1.48K | 1.01K |
| Total | +849.00 | -$2.64K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
1.32K shares
Shares
−1.32K
Strike price
Held after
2.68K
Exercisable
—
1/3/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
6K shares
Shares
+6K
Strike price
5.7
Held after
6K
Exercisable
—
1/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.32K shares | 1/3/2025 | M · Option Exercise | −1.32K | — | 2.68K | |
| Stock Option (right to buy) Direct | Common Stock6K shares | 1/3/2025 | A · Award | +6K | 5.7 | — | 6K |